Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Validation of the CHADS2 clinical prediction rule to predict ischaemic stroke. A systematic review and meta-analysis.

Keogh C, Wallace E, Dillon C, Dimitrov BD, Fahey T.

Thromb Haemost. 2011 Sep;106(3):528-38. doi: 10.1160/TH11-02-0061. Review.

PMID:
21800003
2.

Prognostic value of the ABCD² clinical prediction rule: a systematic review and meta-analysis.

Galvin R, Geraghty C, Motterlini N, Dimitrov BD, Fahey T.

Fam Pract. 2011 Aug;28(4):366-76. doi: 10.1093/fampra/cmr008. Review.

PMID:
21486940
3.
5.

Stroke prediction using mean platelet volume in patients with atrial fibrillation.

Ha SI, Choi DH, Ki YJ, Yang JS, Park G, Chung JW, Koh YY, Chang KS, Hong SP.

Platelets. 2011;22(6):408-14. doi: 10.3109/09537104.2011.560306.

PMID:
21599611
6.

Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independently.

Crandall MA, Horne BD, Day JD, Anderson JL, Muhlestein JB, Crandall BG, Weiss JP, Lappé DL, Bunch TJ.

Pacing Clin Electrophysiol. 2009 May;32(5):648-52. doi: 10.1111/j.1540-8159.2009.02339.x.

PMID:
19422587
7.

Effectiveness of risk stratification according to CHADS2 score in Japanese patients with nonvalvular atrial fibrillation.

Masaki N, Suzuki M, Iwatsuka R, Mizukami A, Kumasaka L, Nagahori W, Ohno M, Matsumura A, Maruyama Y, Hashimoto Y.

Int Heart J. 2009 May;50(3):323-9. Erratum in: Int Heart J. 2009 Jul;50(4):543.

8.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

9.

Ischaemic cardiovascular mortality in patients with non-valvular atrial fibrillation according to CHADS₂ score.

Kim YD, Cha MJ, Kim J, Lee DH, Lee HS, Nam CM, Nam HS, Heo JH.

Thromb Haemost. 2011 Apr;105(4):712-20. doi: 10.1160/TH10-11-0692.

PMID:
21301786
10.

Usefulness of CHADS2 score to predict C-reactive protein, left atrial blood stasis, and prognosis in patients with nonrheumatic atrial fibrillation.

Maehama T, Okura H, Imai K, Yamada R, Obase K, Saito K, Hayashida A, Neishi Y, Kawamoto T, Yoshida K.

Am J Cardiol. 2010 Aug 15;106(4):535-8. doi: 10.1016/j.amjcard.2010.03.067.

PMID:
20691312
11.

Effect of setting, monitoring intensity and patient experience on anticoagulation control: a systematic review and meta-analysis of the literature.

Dolan G, Smith LA, Collins S, Plumb JM.

Curr Med Res Opin. 2008 May;24(5):1459-72. doi: 10.1185/030079908X297349 . Review.

PMID:
18402715
12.

Meta-analysis of CHADS2 Score in Predicting Atrial Fibrillation.

Yang Y, Zhang Z, Ng CY, Li G, Liu T.

Am J Cardiol. 2015 Aug 15;116(4):554-62. doi: 10.1016/j.amjcard.2015.05.010.

PMID:
26071992
13.
14.

[New international guidelines on antithrombotic therapy in atrial fibrillation].

Tveit A.

Tidsskr Nor Laegeforen. 2009 Jun 25;129(13):1332-5. doi: 10.4045/tidsskr.08.0448. Norwegian.

15.

Usefulness of CHADS2 score for prognostic stratification of patients with coronary artery disease: A systematic review and meta-analysis of cohort studies.

Zhou X, Cao K, Kou S, Qu S, Li H, Yu Y, Wang C, Liu Y, Li P, Li D.

Int J Cardiol. 2017 Feb 1;228:906-911. doi: 10.1016/j.ijcard.2016.11.114.

PMID:
27912198
16.

Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors.

Crandall MA, Horne BD, Day JD, Anderson JL, Muhlestein JB, Crandall BG, Weiss JP, Osborne JS, Lappé DL, Bunch TJ.

Pacing Clin Electrophysiol. 2009 Aug;32(8):981-6. doi: 10.1111/j.1540-8159.2009.02427.x.

PMID:
19659615
17.

Relationship between CHADS2 score and ischemic stroke during rhythm control therapy for paroxysmal atrial fibrillation.

Komatsu T, Tachibana H, Sato Y, Ozawa M, Kunugida F, Orii M, Nakamura M.

Int Heart J. 2010 Jan;51(1):24-9.

18.
20.

Risk score for in-hospital ischemic stroke mortality derived and validated within the Get With the Guidelines-Stroke Program.

Smith EE, Shobha N, Dai D, Olson DM, Reeves MJ, Saver JL, Hernandez AF, Peterson ED, Fonarow GC, Schwamm LH.

Circulation. 2010 Oct 12;122(15):1496-504. doi: 10.1161/CIRCULATIONAHA.109.932822.

Supplemental Content

Support Center